These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5814305)

  • 1. Urinary excretion of a low molecular weight protein in cerebral damage.
    Ericsson J; Link H; Zettervall O
    Neurology; 1969 Jun; 19(6):606-10. PubMed ID: 5814305
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the oxido-reductive reaction in the cerebrospinal fluid].
    Rymczonek C
    Neurol Neurochir Pol; 1968; 2(4):485-90. PubMed ID: 4302048
    [No Abstract]   [Full Text] [Related]  

  • 3. [Partial pressure of oxygen and carbon dioxide in cerebrospinal fluid and arterial blood in malignant and vascular cerebral diseases and craniocerebral injuries. Preliminary communication].
    Mrówka R; Wencel T; Zolnierczyk Z
    Neurol Neurochir Pol; 1973; 7(6):825-8. PubMed ID: 4768630
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relationship of changes of protein fraction of blood serum and cerebrospinal fluid to the degree of neurologic findings and localization of the process].
    Bartko D; Danisová J; Wagnerová M
    Bratisl Lek Listy; 1968; 49(2):167-9. PubMed ID: 5669490
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerebrospinal fluid lactate dehydrogenase in neurological patients.
    Hardy JS; Holmes JE
    Bull Los Angeles Neurol Soc; 1967 Oct; 32(4):208-12. PubMed ID: 6056724
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the method of ultraviolet spectrophotometry of cerebrospinal fluid].
    Brio AN
    Lab Delo; 1969; 1():41-2. PubMed ID: 4185359
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnostic value of quantitative and qualitative variations in cerebrospinal fluid proteins].
    Olischer RM
    Psychiatr Neurol Med Psychol (Leipz); 1977 Aug; 29(8):449-64. PubMed ID: 73198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Albumin and IGG in the CSF as demonstration of blood-brain barrier damage and of immune response within the CNS (author's transl)].
    Cognazzo A; Gerbino Promis PC; Grasso E
    Riv Patol Nerv Ment; 1981; 101(3):151-64. PubMed ID: 7256113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the origin of changes in serum protein fractions in cerebrovascular disorders].
    Bartko D; Danisová J; Wágnerová M
    Cas Lek Cesk; 1968 Mar; 107(13):387-94. PubMed ID: 5664816
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cerebrospinal fluid in cerebrovascular disorders].
    Iivanainen M; Taskinen E
    Duodecim; 1973; 89(5):432-9. PubMed ID: 4727010
    [No Abstract]   [Full Text] [Related]  

  • 11. [Increase of the protein level in the cerebrospinal fluid in cerebral infarction].
    Dowzenko A; Dambska M; Ostrowska D; Karwowski B
    Neurol Neurochir Psychiatr Pol; 1966 Nov; 16(11):1299-308. PubMed ID: 5974581
    [No Abstract]   [Full Text] [Related]  

  • 12. The determination of transaminase activity in cerebro-spinal fluid. A study of 192 cases of cerebrovascular lesions and of 50 tumors of the brain.
    FAZIO C; FIESCHI C; SORIANI S
    Confin Neurol; 1961; 21():326-44. PubMed ID: 13891908
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nerve tissue protein S 100 level in the cerebrospinal fluid as an indicator of the extent of brain damage in cerebral ischemic stroke. Experimental study of a rat model of stroke].
    Kotwica Z; Persson L; Hårdemark HG; Påhlman S
    Neurol Neurochir Pol; 1989; 23(3):203-7. PubMed ID: 2634820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in the protein makeup of the cerebrospinal fluid in cerebral stroke].
    Tonkova NV; Shvarev AI; Marchenkova RL; Shtempel' AN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(1):61-4. PubMed ID: 4466235
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cerebrospinal fluid syndromes in stroke].
    Lobkova TN
    Sov Med; 1982; (4):22-5. PubMed ID: 7101052
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the concentration of serotonin in the blood and cerebrospinal fluid in acute cerebral circulatory disorders].
    Berzin' IuE; Auna ZP; Brezinskiĭ GIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(7):1011-5. PubMed ID: 5368909
    [No Abstract]   [Full Text] [Related]  

  • 17. [Double protein-cerebrospinal fluid test for the identification of blood contaminants in bloody cerebrospinal fluid].
    Guĭtur MI; Guĭtur MM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(12):1802-4. PubMed ID: 7340321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selectivity of proteinuria: an evaluation of the immunochemical and gel filtration techniques.
    Pesce AJ; Gaizutis M; Pollak VE
    J Lab Clin Med; 1970 Apr; 75(4):586-606. PubMed ID: 4986371
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fibronectin levels in the blood and cerebrospinal fluid in cerebrovascular diseases].
    Bakunts GO; Ku'lberg AIa; Oganian RR; Seliksetian MS; Gabrielian MS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(9):35-8. PubMed ID: 2609825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proteins in the cerebrospinal fluid in patients with cerebrovascular diseases: determination by Lowry's method].
    Kotoku T; Izumi N; Ito K
    Rinsho Byori; 1972 Apr; 20(4):274-8. PubMed ID: 5066525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.